Recent publications published by researchers at the MRC WIMM.
Temporal changes in erythroid progenitors in critically ill patients: a prospective cohort study
Scott C. et al, (2024), Haematologica
Why cells need iron: a compendium of iron utilisation.
Teh MR. et al, (2024), Trends Endocrinol Metab
Ancient genomic linkage couples metabolism with erythroid development.
Preston AE. et al, (2023), bioRxiv
Hepcidin-guided screen-and-treat interventions for young children with iron-deficiency anaemia in The Gambia: an individually randomised, three-arm, double-blind, controlled, proof-of-concept, non-inferiority trial.
Wegmüller R. et al, (2023), Lancet Glob Health, 11, e105 - e116
Defective iron homeostasis and hematological abnormalities in Niemann-Pick disease type C1
Chen OCW. et al, (2022), Wellcome Open Research, 7, 267 - 267
An Ancient Transcriptional Hub Couples Developmentally Regulated Gene Expression with Metabolism during Erythropoiesis
Preston AE. et al, (2022), BLOOD, 140
Defective iron homeostasis and hematological abnormalities in Niemann-Pick disease type C1.
Chen OCW. et al, (2022), Wellcome Open Res, 7
Defective iron homeostasis and hematological abnormalities in Niemann-Pick disease type C1.
Chen OCW. et al, (2022), Wellcome open research, 7
Evaluation of perturbed iron-homeostasis in a prospective cohort of patients with COVID-19.
Frost JN. et al, (2022), Wellcome open research, 7
Evaluation of perturbed iron-homeostasis in a prospective cohort of patients with COVID-19.
Frost JN. et al, (2022)
TB or not TB? Soft pity opens the iron gates.
Armitage AE. and Drakesmith H., (2021), Blood, 138, 1285 - 1287
The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review.
James PT. et al, (2021), J Nutr, 151, 1854 - 1878
Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection.
Frost JN. et al, (2021), Med, 2, 164 - 179.e12
Analysis of Iron and Iron-Interacting Protein Dynamics During T-Cell Activation.
Teh MR. et al, (2021), Front Immunol, 12
Optimizing hepcidin measurement with a proficiency test framework and standardization improvement.
Aune ET. et al, (2020), Clin Chem Lab Med
Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia.
Arezes J. et al, (2020), Blood, 135, 547 - 557